Caprock Group, Inc. Vertex Pharmaceuticals Inc Transaction History

Caprock Group, Inc.

$2.71 Billion
Q3 2024

A detailed history of Caprock Group, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Caprock Group, Inc. holds 38,088 shares of VRTX stock, worth $15.5 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares

38,088

Previous 37,930 0.42%

Holding current value

$15.5 Million

Previous $17.8 Million 0.37%

% of portfolio

0.65%

Previous 0.73%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$460.0 - $505.78 $72,680 - $79,913	158 Added 0.42%	38,088 $17.7 Million
Q2 2024 Aug 06, 2024	BUY	$392.81 - $485.53 $13.8 Million - $17 Million	35,045 Added 1214.73%	37,930 $17.8 Million
Q1 2024 Apr 29, 2024	BUY	$407.69 - $446.08 $4,484 - $4,906	11 Added 0.38%	2,885 $1.21 Million
Q4 2023 Jan 18, 2024	BUY	$343.0 - $410.68 $104,958 - $125,668	306 Added 11.92%	2,874 $1.17 Million
Q3 2023 Oct 18, 2023	BUY	$338.18 - $362.46 $14,879 - $15,948	44 Added 1.74%	2,568 $892,000
Q2 2023 Aug 10, 2023	BUY	$314.42 - $351.91 $80,805 - $90,440	257 Added 11.34%	2,524 $888,000
Q1 2023 Apr 26, 2023	SELL	$283.23 - $323.1 $13,878 - $15,831	-49 Reduced 2.12%	2,267 $714,000
Q4 2022 Jan 23, 2023	BUY	$285.76 - $321.48 $43,435 - $48,864	152 Added 7.02%	2,316 $0
Q3 2022 Nov 07, 2022	BUY	$273.83 - $305.53 $11,227 - $12,526	41 Added 1.93%	2,164 $627,000
Q2 2022 Jul 26, 2022	SELL	$234.96 - $292.55 $291,585 - $363,054	-1,241 Reduced 36.89%	2,123 $598,000
Q1 2022 Apr 12, 2022	SELL	$221.42 - $260.97 $11,956 - $14,092	-54 Reduced 1.58%	3,364 $878,000
Q4 2021 Jan 18, 2022	BUY	$177.01 - $223.45 $346,054 - $436,844	1,955 Added 133.63%	3,418 $751,000
Q3 2021 Oct 07, 2021	SELL	$181.39 - $202.99 $62,035 - $69,422	-342 Reduced 18.95%	1,463 $265,000
Q2 2021 Aug 13, 2021	BUY	$187.49 - $221.1 $60,934 - $71,857	325 Added 21.96%	1,805 $364,000
Q1 2021 Apr 29, 2021	SELL	$207.02 - $241.31 $33,537 - $39,092	-162 Reduced 9.87%	1,480 $318,000
Q4 2020 Jan 29, 2021	SELL	$207.01 - $276.09 $93,568 - $124,792	-452 Reduced 21.59%	1,642 $388,000
Q3 2020 Oct 29, 2020	BUY	$255.65 - $303.1 $58,799 - $69,713	230 Added 12.34%	2,094 $570,000
Q2 2020 Aug 05, 2020	BUY	$225.48 - $295.8 $420,294 - $551,371	1,864 New	1,864 $541,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caprock Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Caprock Group, Inc. with notifications on news.

Account

Caprock Group, Inc. Vertex Pharmaceuticals Inc Transaction History